Operating

Amortization

Merck & Co. Amortization decreased by 4.3% to $931.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.9%, from $597.00M to $931.00M. Over 4 years (FY 2021 to FY 2025), Amortization shows an upward trend with a 14.3% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026May 4, 2026

How to read this metric

Higher amortization often signals significant past M&A activity or heavy investment in intellectual property, whereas lower levels suggest fewer intangible assets being written off.

Detailed definition

This represents the non-cash charge associated with the write-down of intangible assets, such as patents, software, or a...

Peer comparison

Standard for technology companies with significant intellectual property portfolios; peers often report this separately from tangible depreciation.

Metric ID: operating_adjustment_for_amortization

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$357.00M$360.00M$405.00M$699.00M$464.00M$460.00M$462.00M$543.00M$477.00M$562.00M$462.00M$473.00M$614.00M$633.00M$675.00M$597.00M$601.00M$622.00M$973.00M$931.00M
QoQ Change+0.8%+12.5%+72.6%-33.6%-0.9%+0.4%+17.5%-12.2%+17.8%-17.8%+2.4%+29.8%+3.1%+6.6%-11.6%+0.7%+3.5%+56.4%-4.3%
YoY Change+30.0%+27.8%+14.1%-22.3%+2.8%+22.2%+0.0%-12.9%+28.7%+12.6%+46.1%+26.2%-2.1%-1.7%+44.1%+55.9%
Range$357.00M$973.00M
CAGR+22.4%
Avg YoY Growth+17.0%
Median YoY Growth+18.1%

Product Breakdown

View all
SegmentQ1 '23Q3 '23
Alliance revenue - Lenvima$72.00M$81.00M
Total$543.00M$562.00M

Alliance revenue - Lenvima was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Amortization at Other Companies

Frequently Asked Questions

What is Merck & Co.'s amortization?
Merck & Co. (MRK) reported amortization of $931.00M in Q1 2026.
How has Merck & Co.'s amortization changed year-over-year?
Merck & Co.'s amortization increased by 55.9% year-over-year, from $597.00M to $931.00M.
What is the long-term trend for Merck & Co.'s amortization?
Over 4 years (2021 to 2025), Merck & Co.'s amortization has grown at a 14.3% compound annual growth rate (CAGR), from $1.64B to $2.79B.
What does amortization mean?
The non-cash expense related to the gradual write-down of intangible asset values.